Cross-sectional survey of SARS-CoV-2 testing at US airports and one health department's proactive management of travelers.
Anna ShaumArgelia FigueroaDanica LeeAllison ErtlErin RothneyDenise BorntragerEmily DavenportReena K GulatiClive M BrownPublished in: Tropical diseases, travel medicine and vaccines (2022)
As of December 2020, nearly half of surveyed US airports had SARS-CoV-2 testing sites. Such large-scale adoption of airport testing for a communicable disease is unprecedented and presents new challenges for travelers, airlines, airports, and public health authorities. This assessment was completed before the US and other countries began enforcing entry testing requirements; testing at airports will likely increase as travel demand returns and test requirements for travel evolve. Lessons from Denver demonstrate how HDs can play a key role in engaging airport testing sites to ensure people who test positive for SARS-CoV-2 immediately before travel do not travel on commercial aircraft.